Bone mass measurements in men and women with chronic kidney disease

Area of Science:

• Nephrology
• Orthopedics
• Bone Metabolism

Background:

• Fractures present a significant health risk for individuals with chronic kidney disease (CKD), contributing to increased morbidity and mortality.
• While bone mass measurements are standard for fracture risk assessment in the general population, their effectiveness in CKD patients remains uncertain.

Purpose of the Study:

• To review the epidemiology and causes of fractures in patients with chronic kidney disease (CKD).
• To summarize existing research on the relationship between bone mass measurements and fracture risk in CKD.
• To evaluate the clinical utility of bone density testing for predicting fractures in CKD patients.

Main Methods:

• Systematic review of published literature.
• Analysis of data correlating bone mass measurements with fracture incidence in CKD cohorts.
• Evaluation of dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) limitations in CKD.

Main Results:

• Fractures in CKD result from a combination of compromised bone quantity, impaired bone quality, and neuromuscular dysfunction.
• Technical limitations of bone mineral density (BMD) testing, including DXA and pQCT, restrict its predictive value for fractures in CKD.
• The utility of BMD testing is particularly limited in advanced stages of CKD (stages 4 and 5).

Conclusions:

• Routine bone mineral density testing is not advised for patients with chronic kidney disease (CKD).
• The complex factors contributing to fractures in CKD, alongside BMD testing limitations, necessitate alternative approaches.
• Further research is required to identify noninvasive methods, potentially combined with BMD, for accurate fracture risk prediction in CKD.